Carbohydrate‐Based Vaccines and Immunotherapies 2008
DOI: 10.1002/9780470473283.ch11
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Cancer Vaccines: Clinical Trials and Applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 115 publications
0
3
0
Order By: Relevance
“…Is the binding of modified carbohydrates, as in the case of PSA, a general principle, not only of basic, but also of clinical interest, for instance, in relation to cancer immunotherapy? Different active and passive vaccines, including carbohydrate-based vaccines to aberrant glycostructures, are under clinical trials but have had limited success at proof of principle and efficacy stages [ 33 ]. Characteristic PSA glycoforms bound to IgM, as emerged from this study, direct further investigations to structural comparison of different tumor markers found in immune complexes and their free forms and hold promise for advancement of their use as targets for cancer detection and therapy.…”
Section: Discussionmentioning
confidence: 99%
“…Is the binding of modified carbohydrates, as in the case of PSA, a general principle, not only of basic, but also of clinical interest, for instance, in relation to cancer immunotherapy? Different active and passive vaccines, including carbohydrate-based vaccines to aberrant glycostructures, are under clinical trials but have had limited success at proof of principle and efficacy stages [ 33 ]. Characteristic PSA glycoforms bound to IgM, as emerged from this study, direct further investigations to structural comparison of different tumor markers found in immune complexes and their free forms and hold promise for advancement of their use as targets for cancer detection and therapy.…”
Section: Discussionmentioning
confidence: 99%
“…The available published data testify to low toxicity of some close analogs. For example, in vitro and in vivo experiments showed that the hydrazide derivatives can induce the death of neoplastic cells without harming healthy cells (Wandall and Tarp, 2008). Antitubercular 1,3,4-thiadiazoles demonstrated low mutagenicity and toxicity against proliferating cell lines and isolated human hepatocytes (Karabanovich et al, 2016).…”
Section: Compoundmentioning
confidence: 99%
“…The C(=S)-NH- group [3,4] and the -NH-NH- hydrazide fragment [5,6,7] play a very important role owing to their potentially high antifungal, antibacterial [8,9], antiviral (HIV-1) [10] and anti-malarial activity. Recent research has demonstrated the anticarcinogenic potential of modified hydrazide derivatives [11,12,13], and in vitro and in vivo experiments have shown that when administered in very small doses, the discussed compounds can induce the death of neoplastic cells without harming healthy cells [14]. Hydrazide derivatives can be applied in crop protection products, in particular those designed to fight phytopathogenic fungi such as Fusarium solani and Fusarium culmorum which cause head blight and contaminate crops with mycotoxins—Toxic metabolites of their biological activity [15].…”
Section: Introductionmentioning
confidence: 99%